Related Experiment Video
Updated: Aug 18, 2026

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
Published on: March 24, 2017
Single amino acid codon changes detected in louping ill virus antibody-resistant mutants with reduced neurovirulence
Abstract:
Seven mutant viruses were derived from a Scottish strain of louping ill virus using a virus envelope-specific neutralizing monoclonal antibody. None of the mutants was neutralized and immunofluorescence microscopy confirmed that they did not bind to this antibody. Four mutants showed reduced mouse neurovirulence compared with parent virus and two mutants failed to induce protective immune responses in mice challenged with virulent tick-borne encephalitis virus. The mutants with the lowest virulence showed poor or undetectable haemagglutinating activity. The nucleotide sequence of the envelope glycoprotein gene of each of the seven mutants was determined and the deduced amino acid sequence was compared with parent virus. For each mutant, only a single amino acid codon change was detected and all the amino acid substitutions occurred within amino acid positions 308 to 311. A change from the amino acid aspartate to asparagine at amino acid position 308, which represented a potential glycosylation site, was the most effective substitution in reducing mouse neurovirulence. The results demonstrate the importance of critical sites within the envelope glycoprotein as determinants of virus virulence.
Insights
Seven louping ill virus mutants were created. Critical changes in the envelope glycoprotein reduced virus neurovirulence and immune protection, highlighting key sites for virulence.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Louping ill virus (LIV) is a tick-borne flavivirus with significant neurovirulence.
- Understanding the molecular basis of LIV virulence is crucial for developing effective countermeasures.
- Envelope glycoproteins play a key role in flavivirus entry and immune evasion.
Purpose of the Study:
- To generate and characterize LIV mutants with altered properties using a neutralizing monoclonal antibody.
- To investigate the role of specific envelope glycoprotein regions in LIV neurovirulence and immunogenicity.
- To identify critical amino acid substitutions affecting viral virulence.
Main Methods:
- Generation of seven LIV mutants using a neutralizing monoclonal antibody.
- Assessment of viral neutralization, antibody binding, and immunofluorescence microscopy.
- Determination of mouse neurovirulence and protective immune responses against tick-borne encephalitis virus (TBEV).
- Nucleotide and amino acid sequencing of the LIV envelope glycoprotein gene.
Main Results:
- Mutants exhibited resistance to antibody neutralization and failed to bind the specific monoclonal antibody.
- Four mutants displayed reduced mouse neurovirulence; two induced inadequate protective immunity against TBEV.
- Mutants with lowest virulence showed poor or absent haemagglutinating activity.
- Single amino acid substitutions (positions 308-311) were identified in all mutants.
- Aspartate to asparagine substitution at position 308, a potential glycosylation site, most effectively reduced neurovirulence.
Conclusions:
- Specific sites within the LIV envelope glycoprotein are critical determinants of viral virulence.
- Amino acid substitutions, particularly at position 308, significantly impact neurovirulence and immunogenicity.
- Targeting these critical sites offers potential strategies for developing attenuated vaccines or antiviral therapies.
More Related Videos
Related Concept Videos
Viral Mutations
Leaky Scanning
Rabies

